Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K, Date: 2012-03-14, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: CPHI/20120314/10-K_1/1/000.htm SEC Original: cphi10k123111.htm
FORM 10-K x For the fiscal year ended December 31, 2011 or ¨ For the transition period from _________ to _____________ 001-34471 China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 (011) 86 898-6681-1730 Common Stock, par value $0.001 per

---

---

Webplus: CPHI/20120314/10-K_1/5_EX-23.1/000.htm SEC Original: cphi10kex231123111.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-164049 on Form S-3 and Registration Statement No. 333-141734 Post-Effective Amendment No. 1 to Form SB-2 on Form S-3 of our report dated March 14, 2012 relating to the consolidated financial statements of China Pharma Holdings, Inc. and subsidiaries appearing in this

---

---

Webplus: CPHI/20120314/10-K_1/6_EX-31.1/000.htm SEC Original: cphi10kex311123111.htm
CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Zhilin Li, certify that: 1. I have reviewed this Annual Report on Form 10-K of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in

---

---

Webplus: CPHI/20120314/10-K_1/7_EX-31.2/000.htm SEC Original: cphi10kex312123111.htm
CERTIFICATION (Section 302 of the Sarbanes-Oxley Act of 2002) I, Frank Waung, certify that: 1. 2. 3. 4. a. b. c. d. 5. a. b.

---

---

Webplus: CPHI/20120314/10-K_1/8_EX-32.1/000.htm SEC Original: cphi10kex321123111.htm
CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. s/ Zhilin Li / Zhilin Li EX-32.1 8 cphi10kex321123111.htm

---

---

Webplus: CPHI/20120314/10-K_1/9_EX-32.2/000.htm SEC Original: cphi10kex322123111.htm
CERTIFICATION (Section 906 of the Sarbanes-Oxley Act of 2002) (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Frank Waung Chief Financial Officer (principal financial officer and principal accounting officer) EX-32.2 9 cphi10kex322123111.htm

---

Company Information:

Ticker: CPHI, Company: CHINA PHARMA HOLDINGS, INC., Type: 10-K, Date: 2012-03-14, XBRL Interactive FinancialsCIK: 0001106644, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE 570216